Vaccination in pregnancy - Recent developments

Pediatric Infectious Disease Journal

Volumn 37, Issue 2, 2018, Pages 191-193

  Jones, Christine E ^a,b   Calvert, Anna ^c   Le Doare, Kirsty ^c,d,e  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Centre de Formation   (Senegal)

Author keywords

immunization; pregnancy; vaccine

Indexed keywords

CYTOMEGALOVIRUS VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; STREPTOCOCCUS VACCINE; TETANUS TOXOID; VACCINE;

ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG SAFETY; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFLUENZA; PERTUSSIS; PREGNANCY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TETANUS; VACCINATION; FEMALE; PREGNANCY COMPLICATION; PRENATAL CARE; PROCEDURES;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; VACCINATION; VACCINES;

EID: 85044276447     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001822     Document Type: Article

References (11)

1. Wilcox CR, Holder B and Jones CE (2017) Factors Affecting the FcRnMediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy. Front. Immunol. 8:1294. doi: 10.3389/fimmu.2017.01294.
2. Calvert A, Jones CE. Placental transfer of antibody and its relationship to vaccination in pregnancy. Curr Opin Infect Dis. 2017;30:268-273.
3. Andreas NJ, Kampmann B, Mehring Le-Doare K. Human breast milk: A review on its composition and bioactivity. Early Hum Dev. 2015;91:629-635.
4. Khan R, Vandelaer J, Yakubu A, et al. Maternal and neonatal tetanus elimination: From protecting women and newborns to protecting all. Int J Womens Health. 2015;7:171-180.
5. Madhi SA, Cutland CL, Kuwanda L, et al.; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371:918-931.
6. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: An observational study. Lancet. 2014;384:1521-1528.
7. Heath PT, Culley FJ, Jones CE, et al. Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: A landscape analysis. Lancet Infect Dis. 2017;17:e223-e234.
8. Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine. 2003;21:3465-3467.
9. Krause PR, Bialek SR, Boppana SB, et al. Priorities for CMV vaccine development. Vaccine. 2013;32:4-10.
10. Bonhoeffer J, Kochhar S, Hirschfeld S, et al.; GAIA project participants. Global alignment of immunization safety assessment in pregnancy -The GAIA project. Vaccine. 2016;34:5993-5997.
11. Marchant A, Sadarangani M, Garand M, et al. Maternal immunisation: Collaborating with mother nature. Lancet Infect Dis. 2017;17:e197-e208.